TY  - GEN
AU  - Vida, Margarita
AU  - Gavito, Ana Luisa
AU  - Pavón, Francisco-Javier
AU  - Bautista, Dolores
AU  - Serrano, Antonia
AU  - Suarez, Juan
AU  - Arrabal, Sergio
AU  - Decara, Juan
AU  - Romero-Cuevas, Miguel
AU  - Rodríguez De Fonseca, Fernando
AU  - Baixeras, Elena
PY  - 2015
DO  - 10.1242/dmm.019166
SN  - 1754-8403
UR  - http://hdl.handle.net/20.500.12105/18878
AB  - Interleukin-6 (IL-6) has emerged as an important mediator of fatty acid metabolism with paradoxical effects in the liver. Administration of IL-6 has been reported to confer protection against steatosis, but plasma and tissue IL-6 concentrations are...
LA  - eng
PB  - The Company of Biologists
KW  - Interleukin-6
KW  - Liver
KW  - Lipogenesis
KW  - Steatosis
KW  - Acetyl-CoA Carboxylase
KW  - Animals
KW  - Carnitine O-Palmitoyltransferase
KW  - Cytokinesis
KW  - Diet, High-Fat
KW  - Disease Models, Animal
KW  - Hep G2 Cells
KW  - Humans
KW  - Interleukin-6
KW  - Lipogenesis
KW  - Liver
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Phosphorylation
KW  - Recombinant Proteins
KW  - STAT3 Transcription Factor
KW  - Stearoyl-CoA Desaturase
KW  - Suppressor of Cytokine Signaling Proteins
KW  - AMP-Activated Protein Kinases
KW  - Fatty Acid Synthase, Type I
KW  - Non-alcoholic Fatty Liver Disease
TI  - Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
TY  - research article
ER  -